Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Mélusine Larivière"'
Autor:
Amelie Vallet-Courbin, Mélusine Larivière, Agnès Hocquellet, Audrey Hemadou, Sarjapura-Nagaraja Parimala, Jeanny Laroche-Traineau, Xavier Santarelli, Gisèle Clofent-Sanchez, Marie-Josée Jacobin-Valat, Abdelmajid Noubhani
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0170305 (2017)
Cells of the innate and adaptive immune system are key factors in the progression of atherosclerotic plaque, leading to plaque instability and rupture, potentially resulting in acute atherothrombotic events such as coronary artery disease, cerebrovas
Externí odkaz:
https://doaj.org/article/dea397549106467ca89ec9d1c18744c1
Autor:
Marie-Josée Jacobin-Valat, Jeanny Laroche-Traineau, Samuel Bonnet, Florence Ottones, Gisèle Clofent-Sanchez, Mélusine Larivière, Cyril Lorenzato
Publikováno v:
Seminars in Thrombosis and Hemostasis
Seminars in Thrombosis and Hemostasis, Thieme Publishing, 2020, 46 (05), pp.563-586. ⟨10.1055/s-0039-1701019⟩
Seminars in Thrombosis and Hemostasis, Thieme Publishing, 2020, 46 (05), pp.563-586. ⟨10.1055/s-0039-1701019⟩
Atherosclerosis is the major underlying cause of cardiovascular diseases, the prevalence of which is continuously increasing, thus currently standing as the leading global cause of death. This pathology gradually develops over the course of 50 or mor
Publikováno v:
médecine/sciences. 35:1026-1028
Les maladies monogéniques sont des maladies génétiques rares mais très nombreuses, avec une sévérité variable. Les premières utilisations des anticorps monoclonaux dans ces maladies remontent aux années 2000 et de nombreux essais sont désor
Publikováno v:
Chimie et biologie de synthèse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fe3c209a12ccb68a1b366985db1fe76
https://doi.org/10.1051/978-2-7598-2316-1-006
https://doi.org/10.1051/978-2-7598-2316-1-006
Publikováno v:
Medecine sciences : M/S. 35(12)
Monogenic diseases are rare genetic diseases but they are numerous and display a highly variable degree of severity. First uses of monoclonal antibodies to treat monogenic diseases started in the 2000's and many clinical trials are ongoing. Anti-IL-1
Publikováno v:
Medecine sciences : M/S. 35(12)
Autor:
Mélusine, Larivière, Renato, Monteiro
Publikováno v:
Medecine sciences : M/S. 35(12)
Autor:
Geoffrey Prévot, Sylvie Crauste-Manciet, Philippe Barthélémy, Jeanny Laroche-Traineau, Martine Duonor-Cérutti, Mélusine Larivière, Gisèle Clofent-Sanchez, Marie Josée Jacobin-Valat
Publikováno v:
Data in Brief
Data in Brief, Elsevier, 2017, 15, pp.824-827. ⟨10.1016/j.dib.2017.10.058⟩
Data in Brief, 2017, 15, pp.824-827. ⟨10.1016/j.dib.2017.10.058⟩
Data in Brief, Vol 15, Iss, Pp 824-827 (2017)
Data in Brief, Elsevier, 2017, 15, pp.824-827. ⟨10.1016/j.dib.2017.10.058⟩
Data in Brief, 2017, 15, pp.824-827. ⟨10.1016/j.dib.2017.10.058⟩
Data in Brief, Vol 15, Iss, Pp 824-827 (2017)
International audience; This article present data related to the publication entitled "Iron oxide core oil-in-water nanoemulsion as tracer for atherosclerosis MPI and MRI imaging" (Prévot et al., 2017) [1]. Herein we describe the engineering in the
Autor:
Mélusine Larivière, Renato C. Monteiro
Publikováno v:
médecine/sciences. 35:1206-1207
Publikováno v:
médecine/sciences. 35:1204-1205